Рамәт-Ғанда ең жақсы Колоноскопия дәрігерлері - ЖОҒ-5 дәрігерлер

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

General Surgeon | Upper Gastrointestinal & Oncologic Surgery Expert

Forbes Israel’s “Best Doctors” list (2025)

Areas of Expertise

Dr. Yuri Goldes specializes in advanced surgical treatment of complex gastrointestinal conditions, with a focus on minimally invasive and robotic approaches:

Diaphragmatic Hernia

Advanced laparoscopic and robotic hernia repair techniques

Achalasia

Modern minimally invasive solutions for esophageal motility disorders

Gastroesophageal Reflux Disease (GERD)

Innovative laparoscopic and robotic surgical treatments

Pancreatic Cancer

Comprehensive surgical management using minimally invasive and robotic methods

Gastric (Stomach) Cancer

Precision surgery with advanced laparoscopic and robotic technologies

Esophageal Cancer

High-precision minimally invasive and robot-assisted resections

Cholecystectomy (Gallbladder Removal)

Laparoscopic gallbladder surgery using modern techniques

About the Doctor

Dr. Yuri Goldes is a highly experienced general surgeon specializing in upper gastrointestinal surgery, including procedures involving the pancreas, stomach, and esophagus.

With over 20 years of clinical experience, he is recognized as a leading expert in oncologic surgery of the upper GI tract, consistently applying cutting-edge laparoscopic and robotic techniques to achieve optimal outcomes and faster patient recovery.

Dr. Goldes has been involved in pioneering surgical procedures in Israel, including performing some of the first robotic oncologic resections of the stomach and pancreas in the country.

He is also among a select group of surgeons worldwide who perform minimally invasive pancreaticoduodenectomy (Whipple procedure) using advanced laparoscopic techniques — one of the most complex operations in abdominal surgery.

Clinical Approach

Dr. Goldes combines:

Extensive surgical expertise

Decades of hands-on experience

Advanced minimally invasive technologies

with a strong commitment to personalized patient care, ensuring that each treatment plan is tailored to the individual needs of the patient.

Positions & Recognition

Deputy Director, Department of General Surgery and Transplantation

Head of Upper Gastrointestinal Surgery Unit, Sheba Medical Center (Tel Aviv)

Ranked among the Best Gastrointestinal Surgeons in Israel (Forbes)

Awarded Best Doctor of the Year (2019) by the Israeli Ministry of Health

Included in Forbes Israel’s “Best Doctors” list (2025)

Included in Forbes Israel’s “Best Doctors” List (2025)

Medical Oncologist | Radiotherapist | Director of Cancer Center

Areas of Expertise

Professor Raanan Berger specializes in medical oncology and radiation therapy, with a strong focus on genitourinary cancers and translational research:

Genitourinary Oncology

Advanced treatment of prostate and related cancers

Prostate Cancer

Comprehensive care including systemic therapy and radiotherapy

Oncology & Radiotherapy

Personalized cancer treatment using modern therapeutic approaches

Molecular Oncology Research

Study of prostate and breast tumorigenesis mechanisms

About the Doctor

Professor Raanan Berger is a leading medical oncologist and radiotherapist, serving as the Director of the Cancer Center at Sheba Medical Center.

He also heads the clinical research unit within the Institute of Oncology and Radiotherapy, where he is actively involved in advancing innovative cancer therapies.

Prof. Berger has played a key role in developing a comprehensive patient support program, integrating medical treatment with psychological and social care. This multidisciplinary model ensures that patients and their families receive not only cutting-edge oncology care, but also continuous emotional and supportive guidance throughout the treatment process.

He leads the genitourinary oncology program, with a particular focus on prostate cancer, and runs a basic and translational research laboratory investigating molecular mechanisms involved in prostate and breast cancer development.

Professor Berger is the co-author of over 20 peer-reviewed scientific publications.

Education and Training

MD and PhD, School of Medicine, Tel Aviv University, Israel

Clinical training in Medical Oncology and Radiotherapy, Sheba Medical Center

Postdoctoral fellowship, Dana-Farber Cancer Institute, Harvard Medical School

During his fellowship, Prof. Berger combined clinical work in prostate cancer treatment (in collaboration with Dr. Philip Kantoff) with advanced research in molecular oncology in the laboratory of Dr. William C. Hahn.

Board Certifications

Oncology

Professional Memberships

Member of European Society for Medical Oncology (ESMO)

Member of American Society of Clinical Oncology (ASCO)

Research & Publications

Professor Berger has contributed to important clinical and scientific research, including:

Classification of high-risk vs. very high-risk prostate cancer and its impact on outcomes of radiotherapy and androgen deprivation therapy

Research on inherited mutations in BRCA1 and BRCA2 genes in large international cohorts